Cytoplasmic sequestration of Rel proteins by IκBα requires CRM1- dependent nuclear export

Molecular and Cellular Biology

Volumn 20, Issue 6, 2000, Pages 2269-2284

  Tam, Winnie F ^a   Lee, Linda H ^a,b   Davis, Laura ^a   Sen, Ranjan ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTOMYCIN B;

ARTICLE; CYTOPLASM; DNA BINDING; GENETIC TRANSCRIPTION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; T LYMPHOCYTE;

ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; COS CELLS; CYTOPLASM; GENES, REL; I-KAPPA B PROTEINS; KARYOPHERINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS V-REL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SACCHAROMYCES CEREVISIAE;

MAMMALIA;

EID: 0033998441     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.6.2269-2284.2000     Document Type: Article

References (33)

1. Arenzana-Seisdedos, P., J. Thompson, M. Rodriguez, F. Bachelerie, D. Thomas, and R. T. Hay. 1995. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell. Biol. 15:2689-2696.
2. Arenzana-Seisdedos, P., P. Turpin, M. Rodriguez, D. Thomas, R. T. Hay, J. L. Virelizier, and C. Dargemont. 1997. Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm. J. Cell. Sci. 110:369-378.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Sezdman, J. A. Smith, and K. Struhl (ed.). 1987. Preparation of protein extracts from yeast, p. 13.13.4. In Current protocols in molecular biology, vol. 2. John Wiley & Sons, New York, N.Y.
4. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
5. Cheng, J. D., R. P. Ryseck, R. M. Attar, D. Dambach, and R. Bravo. 1998. Functional redundancy of the nuclear factor KB inhibitors IκBα and IκBβ. J. Exp. Med. 188:1055-1062.
6. Epinat, J. C., S. T. Whiteside, N. R. Rice, and A. Israel. 1997. Reconstitution of the NFκB system in Saccharomyces cerevisiae for isolation of effectors by phenotype modulation. Yeast 13:599-612.
7. Finley, R. L., Jr., and R. Brent. 1997. Two-Hybrid analysis of genetic regulatory networks, p. 197-214. In P. L. Bartel and S. Fields (ed.), The yeast two-hybrid system. Oxford University Press, New York, N.Y.
8. Franzoso, G., L. Carlson, T. Scharton-Kersten, E. W. Shores, S. Epstein, A. Grinberg, T. Tran, F. Shacter, A. Leonardi, M. Anver, P. Love, A. Sher, and U. Siebenlist. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture and germinal center reactions. Immunity 6:479-490.
9. Fukuda, M., S. Ano, T. Nakamura, M. Adachi, M. Yoshida, M. Yanagida, and E. Nichida. 1997. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390:308-311.
10. Grimm, S., and P. A. Baeuerle. 1993. The inducible transcription factor NFκB: structure-function relationship of its protein subunits. Biochem. J. 290:297-308.
11. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
12. Jamieson, C., P. G. McCaffrey, A. Rao, and R. Sen. 1991. Physiologic activation of T cells via the T cell receptor induces NFκB. J. Immunol. 147:415-420.
13. Kahana, J. A., and P. A. Silver. 1996. Use of the A. Victoria Green fluorescent protein to study protein dynamics in vivo. Curr. Protocols Mol. Biol. 1(Suppl. 34):9.7.22-9.7.28.
14. Klement, J. F., N. R. Rice, B. D. Car, S. J. Abbondanzo, G. D. Powers, H. Bhatt, C. H. Chen, C. A. Rosen, and C. L. Stewart. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349.
15. Kudo, N., B. Wolff, T. Sekimoto, E. P. Schreiner, Y. Yoneda, M. Yanagida, S. Horinouchi, and M. Yoshida. 1998. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:540-547.
16. Lenardo, M., and U. Siebenlist. 1994. Bcl-3-mediated nuclear regulation of the NFκB trans-activating factor. Immunol. Today 15:145-147.
17. Macreadie, I. G., M. N. Jagadish, A. A. Azad, and P. R. Vaughan. 1989. Versatile cassettes designed for the copper inducible expression of proteins in yeast plasmid. Plasmid 21:147-150.
18. May, M. J., and S. Ghosh. 1997. Rel/NF-κB and IκB proteins: an overview. Semin. Cancer Biol. 8:63-73.
19. Nelsen, B., G. Tian, B. Erman, J. Gregoire, R. Maki, B. Graves, and R. Sen. 1993. Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS-domain proteins. Science 261:82-86.
20. Neville, M., F. Stutz, L. Lee, L. I. Davis, and M. Rosbash. 1997. The importin-β family member Crmlp bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7:767-775.
21. Ossareh-Nazari, B., F. Bachelerie, and C. Dargemont. 1997. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science 278:141-144.
22. Phillips, R. J., and S. Ghosh. 1997. Regulation of IκBβ in WEHI 231 mature B cells. Mol. Cell. Biol. 17:4390-4396.
23. Rodriguez, M. S., J. Thompson, R. T. Hay, and C. Dargemont. 1999. Nuclear retention of IκBα protects it from signal-induced degradation and inhibits nuclear factor κB transcriptional activation. J. Biol. Chem. 274:9108-9115.
24. Sachdev, S., and M. Hannink. 1998. Loss of IκBα-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel. Mol. Cell. Biol. 18:5445-5456.
25. Sachdev, S., A. Hoffmann, and M. Hannink. 1998. Nuclear localization of IκBα is mediated by the second ankyrin repeat: the IκBα ankyrin repeats define a novel class of cis-acting nucleas import sequences. Mol. Cell. Biol. 18:2524-2534.
26. Schwarz, E. M., P. Krimpenfort, A. Berns, and I. M. Verma. 1997. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11:187-197.
27. Scott, M. L., T. Fujita, H.-C. Liou, G. P. Nolan, and D. Baltimore. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev. 7:1266-1276.
28. Souyang, H., R. Phillips, I. Douglas, and S. Ghosh. 1996. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16:5444-5449.
29. Verma, I. M., J. K. Stevenson, E. M. Schwartz, D. Van Antwerp, and S. Miyamoto. 1998. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
30. Weil, R., S. T. Whiteside, and A. Israel. 1997. Control of NFκB activity by the IκBβ inhibitor. Immunobiology 198:14-23.
31. Whiteside, S. T., and A. Israel. 1997. IκB proteins: structure, function and regulation. Semin. Cancer Biol. 8:75-82.
32. Yan, C., L. H. Lee, and L. I. Davis. 1998. Crmlp mediates regulated nuclear export of a yeast AP-1-like transcription factor. EMBO J. 17:7416-7429.
33. Zabel, U., T. Henkel, M. S. Silver, and P. A. Baeuerle. 1993. Nuclear uptake control of NFκB by MAD-3, and IκB protein present in the nucleus. EMBO J. 12:201-211.